ReviewEndocrinology2025
Genomic Crosstalk Between Nuclear Receptors in Hormone-dependent Cancers.
Review in Endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Remodeling of the hepatic circadian transcriptome across the estrous cycle.bioRxiv : the preprint server for biology · 2026Article
- The Great Escape: the systems biology of endocrine resistance and lineage plasticity.Endocrine-related cancer · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nuclear receptors (NRs) orchestrate transcriptional programs that regulate cell fate decisions, and when these processes are disrupted, they can drive hormone-dependent cancers. This review summarizes mechanisms by which NRs function collectively, or crosstalk, to bring about the complex transcriptional control of cell fate decisions and indicate where these processes can act as cancer drivers. These crosstalk mechanisms include the exchange of coregulators between NRs and as well as genomic convergence of NRs. Evidence is also discussed for how NRs potentially pass through a continuum of interactions as part of a biological ratchet mechanism to regulate gene transcription. In this continuum, pioneer factors drive chromatin competence for NRs and, along with mammalian SWI/SNF complexes, facilitate transient assisted loading between NRs, as well as more stable crosstalk in the form of mitotic bookmarking, which allows inheritance of transcriptional control. NR crosstalk is also sustained through the function of larger and perhaps more stable interactions, such as through the megatrans complex. Also considered to explain NR crosstalk is the established and emerging understanding of the grammar of motif selection, and this is placed in the context of NR network approaches, for example in breast cancer. Finally, a systems-level framework, called NuRome, is discussed that combines high-dimensional data at the cistrome, transcriptome, and proteome levels to provide a predictive understanding of NR crosstalk and transcription in cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.